Endocrine causes of hypertension: literature review and practical approach

JB de Freminville, L Amar, M Azizi… - Hypertension …, 2023 - nature.com
Hypertension (HTN) affects more than 30% of adults worldwide. It is the most frequent
modifiable cardiovascular (CV) risk factor, and is responsible for more than 10 million death …

Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades

V Amodru, N Sahakian, C Piazzola, R Appay… - Pituitary, 2024 - Springer
Purpose Acromegaly is a rare disease associated with chronic multisystem complications.
New therapeutic strategies have emerged in the last decades, combining pituitary …

The experience of diagnosis announcement in rare endocrine diseases: a survey of the French FIRENDO network

H Rahabi, M Givony, B Demaret, F Albarel… - Annales d' …, 2024 - Elsevier
Context Diagnosis announcement of a chronic disease is a crucial moment for patients as
well as for their families and an important step in the management of severe conditions such …

[HTML][HTML] Поражение суставов у пациентов с акромегалией: потенциальные маркеры ранней диагностики

МА Перепелова, АС Луценко… - Ожирение и …, 2024 - omet-endojournals.ru
Аннотация Акромегалия—орфанное нейроэндокринное заболевание, обусловленное
повышенной продукцией гормона роста (ГР) и инсулиноподобного фактора роста—1 …

[PDF][PDF] Personalizovaná léčba akromegalie-predikce terapeutické odpovědi

F Gabalec, J Drugda, J Čáp - Vnitřní lékařství, 2024 - casopisvnitrnilekarstvi.cz
The article deals with the issue of personalized treatment of acromegaly with emphasis on
prediction of therapeutic response. In the context of the rapidly developing field of …

[PDF][PDF] DENTOFACIAL ASPECTS OF ACROMEGALY: CASE REPORT AND REVIEW OF THE LITERATURE

M Ingafou, MA Jaber, EM Elameen, AM Elameen - researchgate.net
Acromegaly is an uncommon condition that results from excessive production of growth
hormone. Most of the cases are due to pituitary adenomas. Craniofacial alterations are a …

[引用][C] L'OPTIMISATION DE LA PRISE EN CHARGE DE L'ACROMEGALIE

PG RAVEROT - 2023